News about Global Pharma

Lykos Therapeutics Announces FDA Acceptance

Lykos Therapeutics Announces FDA Acceptance

The FDA has granted the application priority review and has assigned a Prescription Drug User Fee Act (PDUFA) target action date of August 11, 2024.

Global Pharma | 10/02/2024 | By Manvi 694

Zynex Receives FDA Clearance for Next-Gen M-Wave Neuromuscular Stimulation Device

Zynex Receives FDA Clearance for Next-Gen M-Wave Neuromuscular Stimulation Device

The M-Wave, successor to the renowned E-Wave, revolutionizes NMES treatments with enhanced functionality and a user-friendly design.

Global Pharma | 08/02/2024 | By Manvi 1362

Sibel Health's ANNE One Receives 4th FDA Clearance for Continuous Wearable Vital Signs Monitoring

Sibel Health's ANNE One Receives 4th FDA Clearance for Continuous Wearable Vital Signs Monitoring

This latest clearance expands the capabilities of the ANNE® One platform to include continuous ambulatory ECG monitoring, SpO2, temperature, and non-invasive blood pressure measurements.

Global Pharma | 08/02/2024 | By Manvi 1087

Thermax Acquires TSA Process Equipments

Thermax Acquires TSA Process Equipments

Thermax has signed definitive agreements for acquisition to be completed in due course and will fully acquire the balance stake of the company over the next two years.

Global Pharma | 07/02/2024 | By Manvi 817

AstraZeneca Invests USD 300 Million in Cutting-Edge Cell Therapy Facility in Rockville, MD

AstraZeneca Invests USD 300 Million in Cutting-Edge Cell Therapy Facility in Rockville, MD

The site, strategically located within Maryland's flourishing life sciences corridor and near universities, underscores AstraZeneca's commitment to innovation and talent recruitment.

Global Pharma | 07/02/2024 | By Manvi 439

Empower Pharma Acquires East Windsor Facility for Pharmaceutical Expansion

Empower Pharma Acquires East Windsor Facility for Pharmaceutical Expansion

The companies anticipate completing the transaction in the coming months, subject to the satisfaction of closing conditions.

Global Pharma | 07/02/2024 | By Manvi 595

Brenntag Specialties and KRONOS Extend Agreement for Pharma and Beauty & Personal Care Customers in EMEA

Brenntag Specialties and KRONOS Extend Agreement for Pharma and Beauty & Personal Care Customers in EMEA

The distribution agreement includes KRONOS products for Brenntag Specialties’ customers in Life Science segments, which include pharmaceutical as well as cosmetics and personal care applications.

Global Pharma | 06/02/2024 | By Manvi 288

Zuellig Pharma Expands Healthcare Portfolio with Acquisition of Cialis and Alimta Brands

Zuellig Pharma Expands Healthcare Portfolio with Acquisition of Cialis and Alimta Brands

The acquisition covers Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, and Thailand through its wholly-owned subsidiary, Zanovex Pte. Ltd.

Global Pharma | 05/02/2024 | By Manvi 1800

Aurobindo Pharma's US Subsidiary Eugia to Sell Business Assets for USD 52 Million

Aurobindo Pharma's US Subsidiary Eugia to Sell Business Assets for USD 52 Million

The agreement encompasses Eugia's related assets, liabilities, and employees, as the company strategically focuses on enhancing capacities and operations in other units.

Global Pharma | 05/02/2024 | By Manvi 1265

Gericke Announces Inauguration of its New Production Hall in Switzerland

Gericke Announces Inauguration of its New Production Hall in Switzerland

The state-of-the-art facility marks a significant milestone in the company's commitment to meeting the growing demand for leading-edge technology in the powder processing industry.

Global Pharma | 03/02/2024 | By Manvi 459

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members